G20 Health Ministers’ Meeting in India: Prof. Jakob N. Kather accompanies delegation around Federal Health Minister Prof. Karl Lauterbach

The meeting of the G20 health ministers in India in August 2023 was not only a platform for discussions on the promotion of digital innovations and the expansion of digital structures in the health sector, but also provided space for exchange between the participating countries and experts. Federal Minister of Health Prof. Karl Lauterbach was accompanied by a delegation of leading AI scientists from Germany, including Prof. Jakob N. Kather, Professor of Clinical Artificial Intelligence at the Else Kröner Fresenius Centre for Digital Health at TU Dresden.

Peptide warehouse for the development of personalized immunotherapies to eliminate residual leukemic progenitor cells in acute myeloid leukemia (AML

Immunotherapies are novel and promising treatment options for cancer patients. Many of these immunotherapies aim to activate the so-called T cells as highly effective defense cells of the immune system. T cells recognize foreign surface markers on tumor cells and can then destroy them.
In acute myeloid leukemia, the most common acute blood cancer in adults, leukemic progenitor cells often remain after therapy, leading to a relapse of the disease. Here, T cell-based immunotherapies could help as a new treatment option to specifically target these remaining progenitor cells.

Subscribe to Scientific Funding